InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the detailed record of transactions filed by Humphrey Rachel, Director. Director active across 1 company, notably Pyxis Oncology, Inc.. Aggregated, 3 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €1k. History available since 24 March 2023. The latest transaction was disclosed on 14 April 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Humphrey Rachel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
1,400 股@ US$0.97270.0008% mcap50.0% 占其流量Common StockSEC:0000905148-26-001434:0
38,741 股0Common StockSEC:0000950170-24-038099:0
58,064 股0Common StockSEC:0001209191-23-021408:0
3 条申报中的 3 条
About Humphrey Rachel
Humphrey Rachel is a Director at Pyxis Oncology, Inc. She plays a key role in the governance of the company, contributing to strategic decisions and overseeing operations. Her experience in the biotechnology sector is valuable for the company's development.
